Varicose Vein Treatment Devices – Market Insights – United States

The US varicose vein treatment device market will be characterized by moderate growth and a changing reimbursement landscape for new endovenous ablation and sclerotherapy technologies, which will compete with more established modalities over the forecast period.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for varicose vein treatment devices in the US from 2019 through 2031.

The COVID-19 pandemic has had a strong negative impact on the US varicose vein treatment device market.

To what extent were varicose vein treatment procedures affected in the US?

How fast will procedures recover in the short term?

Nonthermal, nontumescent varicose vein treatment options are becoming increasingly adopted in the US.

How quickly are these modalities being adopted?

How will the recently approved CPT codes for polidocanol microfoam and cyanoacrylate adhesive devices drive adoption?

How will established treatment options, such as ELA and ERFA, compete with these new modalities?

Table of contents